ANL 13.19 Increased By ▲ 0.65 (5.18%)
ASC 12.17 Decreased By ▼ -0.53 (-4.17%)
ASL 13.50 Increased By ▲ 0.04 (0.3%)
BOP 8.31 Decreased By ▼ -0.07 (-0.84%)
BYCO 5.75 Decreased By ▼ -0.21 (-3.52%)
FCCL 17.06 Decreased By ▼ -0.02 (-0.12%)
FFBL 23.61 Decreased By ▼ -0.44 (-1.83%)
FFL 10.05 Increased By ▲ 0.08 (0.8%)
FNEL 9.31 Increased By ▲ 0.06 (0.65%)
GGGL 13.80 Decreased By ▼ -0.20 (-1.43%)
GGL 26.75 Decreased By ▼ -0.30 (-1.11%)
HUMNL 5.66 Decreased By ▼ -0.07 (-1.22%)
JSCL 14.55 Decreased By ▼ -0.45 (-3%)
KAPCO 30.70 Decreased By ▼ -0.90 (-2.85%)
KEL 3.16 Decreased By ▼ -0.06 (-1.86%)
MDTL 2.09 Decreased By ▼ -0.12 (-5.43%)
MLCF 31.90 Decreased By ▼ -0.85 (-2.6%)
NETSOL 89.00 Decreased By ▼ -1.21 (-1.34%)
PACE 4.09 Decreased By ▼ -0.01 (-0.24%)
PAEL 20.42 Decreased By ▼ -0.09 (-0.44%)
PIBTL 7.27 Increased By ▲ 0.02 (0.28%)
POWER 6.31 Decreased By ▼ -0.08 (-1.25%)
PRL 11.80 Decreased By ▼ -0.15 (-1.26%)
PTC 8.69 Decreased By ▼ -0.11 (-1.25%)
SILK 1.19 Increased By ▲ 0.02 (1.71%)
SNGP 37.10 Decreased By ▼ -0.60 (-1.59%)
TELE 14.47 Decreased By ▼ -0.38 (-2.56%)
TRG 79.19 Increased By ▲ 1.51 (1.94%)
UNITY 21.85 Decreased By ▼ -1.05 (-4.59%)
WTL 2.00 Decreased By ▼ -0.03 (-1.48%)
BR100 4,375 Decreased By ▼ -5.63 (-0.13%)
BR30 16,903 Increased By ▲ 39.14 (0.23%)
KSE100 43,044 Decreased By ▼ -188.61 (-0.44%)
KSE30 16,648 Decreased By ▼ -70.18 (-0.42%)

Coronavirus
LOW Source: covid.gov.pk
Pakistan Deaths
28,777
1024hr
Pakistan Cases
1,287,161
33624hr
0.78% positivity
Sindh
476,830
Punjab
443,519
Balochistan
33,507
Islamabad
107,930
KPK
180,383
Pakistan

Pfizer to supply 13mn doses to Pakistan

  • “In the face of this global health crisis, Pfizer’s purpose 'breakthroughs that change patients’ lives' has taken on an even greater urgency. Our hope is that our vaccine will help make this happen.”
21 Jun 2021

ISLAMABAD: Pfizer Pakistan and BioNTech on Monday announced an agreement with the National Disaster Management Authority (NDMA) to supply 13 million doses of their COVID-19 Vaccine (BNT162b2) to Pakistan.

“Deliveries are planned during course of 2021, and we are deeply honored to work with the Pakistan government and to line up our scientific and manufacturing resources toward our shared goal of bringing a COVID-19 vaccine to the people of Pakistan as quickly as possible,” said Syed Muhammad Wajeehuddin, Country Manager Pfizer Pakistan in a statement.

“In the face of this global health crisis, Pfizer’s purpose 'breakthroughs that change patients’ lives' has taken on an even greater urgency. Our hope is that our vaccine will help make this happen.”

“I would like to thank the Pakistan government for its support and putting trust in our ability to develop a vaccine that, we believe, has the potential to help address this global pandemic threat. Our goal remains to deliver a global supply of a well-tolerated and effective COVID-19 vaccine for many people around the world, as quickly as we can,” said Sean Marett, Chief Business and Chief Commercial Officer at BioNTech.

Pfizer and BioNTech aim to manufacture more than three billion doses of their COVID-19 vaccine globally in total by the end of 2021, assuming updated six-dose labeling, continuous process improvements, expansion at current facilities and contingent upon adding new suppliers and contract manufacturers.

The vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer, and the marketing authorization holder is BioNTech in the United States, Europe, UK, Canada, and other countries.

We love hearing your feedback, please help us improve by answering these few survey questions

Comments

Comments are closed.